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Background:  Several  enterovirus  (EV)  genotypes  can result  in  aseptic  meningitis,  but  their routes  of  access
to the central  nervous  system  remain  to be elucidated  and  may differ  between  the  pediatric  and  adult
populations.
Objective:  To  assess  the  pattern  of  viral  shedding  in  pediatric  and  adult  subjects  with  acute  EV meningitis
and  to generate  EV surveillance  data  for Switzerland.
Study design:  All pediatric  and  adult  subjects  admitted  to  the  University  Hospitals  of  Geneva  with  a
diagnosis  of  EV  meningitis  between  2013  and  2015  were  enrolled.  A  quantitative  EV real-time  reverse
transcriptase  (rRT)-PCR  was  performed  on the cerebrospinal  ﬂuid  (CSF),  blood,  stool,  urine  and  respiratory
specimens  to  assess  viral  shedding  and  provide  a comparative  analysis  of pediatric  and  adult  populations.
EV  genotyping  was  systematically  performed.
Results:  EV  positivity  rates  differed  signiﬁcantly  between  pediatric  and  adult subjects;  62.5% of  pediatric
cases  (no adult  case)  were  EV-positive  in  stool  and  blood  for subjects  for  whom  these  samples  were
all  collected.  Similarly,  the  EV  viral  load  in  blood  was signiﬁcantly  higher  in pediatric  subjects.  Blood
C-reactive  protein  levels  were  lower  and the number  of  leucocytes/mm3 in  the  CSF  were  higher  in non-
viremic  than  in viremic  pediatric  subjects,  respectively.  A greater  diversity  of  EV  genotypes  was observed
in pediatric  cases,  with  a predominance  of  echovirus  30  in children  ≥3  years  old  and  adults.
Conclusion:  In contrast  to adults,  EV-disseminated  infections  are  predominant  in  pediatric  subjects  and
show  different  patterns  of  EV viral  shedding.  This  observation  may  be useful  for  clinicians  and contribute
to  modify  current  practices  of  patient  care.
©  2017  The  Author(s).  Published  by Elsevier  B.V.  This  is  an  open  access  article  under  the  CC. Background
Enterovirus (EV) is the major cause of aseptic meningitis [1,2]
ith an incidence peak documented during the warm season in
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the northern hemisphere [3–7]. In most cases, EV meningitis is
self-limited with a low rate of complications or sequelae. Neonates
represent the most susceptible population in terms of morbidity
and mortality rates [2], and a rapid and accurate diagnosis is of
the utmost importance in terms of clinical management to reduce
the length of hospital stay, costs, and antibiotic use [8–11]. At
present, EV meningitis is mainly diagnosed based on the analy-
sis of cerebrospinal ﬂuid (CSF) with EV-speciﬁc real-time reverse
transcription (rRT)-PCR assays. The viral load observed in the CSF
is relatively low and several studies have demonstrated that some
cases of EV-associated meningitis could be missed if only CSF is
e under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
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nvestigated and they recommend to screen blood specimens in
ombination [12–14].
The central nervous system (CNS) invasion remains an unclear
rocess. The two most likely possibilities are that it occurs either
s a consequence of systemic infection by crossing the blood–brain
arrier or via retrograde axonal transport [2]. The fecal–oral route is
he most common mode of EV transmission and the primary sites
f replication are the gastrointestinal or respiratory tracts. It can
e postulated that a signiﬁcant viral replication in the primary site
an then be followed by viremia, thus leading potentially to CNS or
ther organ infections. This hypothesis is essentially based on ani-
al  studies [15–18], and it has not been investigated systematically
or EV infection in humans.
Many EV genotypes circulate worldwide and are responsible for
V-associated meningitis, with a high prevalence of echovirus 30
E30) identiﬁed in recent outbreaks observed in several European
ountries [5,19–23].
. Objectives
To assess the pattern of viral shedding in the CSF, blood, stool,
asopharyngeal and urine specimens in a prospective manner in
uman cases. The respective quantitative viral load in the differ-
nt putative sites of replication or viral shedding in pediatric and
dult subjects with acute EV meningitis was investigated over a
hree-year period, enabling also to investigate potential intra-host
V variability. We  provide also an evaluation of the etiology of
V meningitis in the western part of Switzerland during the same
eriod.
. Study design
.1. Patients
The study was conducted from January 2013 through December
015. All pediatric (<16 years old; n = 37) and adult (≥16 years-
ld; n = 23) patients admitted to the University Hospitals of Geneva
Geneva, Switzerland) with a diagnosis of EV meningitis were con-
idered for study inclusion. Five additional pediatric patients from
he University Hospital Center in Lausanne (Switzerland) were
lso enrolled in 2015. Only patients with a clinical diagnosis of
V-associated meningitis or meningo-encephalitis conﬁrmed by a
ositive EV-speciﬁc rRT-PCR in CSF by the routine laboratory were
ncluded (negative direct CSF examination and/or culture, negative
y r(RT)-PCR for any other virus requested by the physicians such
s herpes simplex virus, varicella zoster virus and/or human pare-
hovirus). After obtaining signed informed consent, the following
pecimens were collected speciﬁcally for the study, if not normally
ollected for clinical care: upper respiratory specimens (nasopha-
yngeal swabs or aspirate), stool or anal swab, and urine. Blood
pecimens were not speciﬁcally collected for the sole purpose of
his study and only leftover plasma or serum specimens collected
or medical reasons were used. Patients had the possibility to refuse
he speciﬁc collection of respiratory, anal and/or urine specimens.
.2. Quantitative rRT-PCR
For each collected specimen, the viral genome was extracted
ndividually from 200 L using the NucliSENS easyMAG
bioMérieux, Geneva, Switzerland) nucleic acid kit, with an
lution volume of 25 L. The quantitative EV-speciﬁc rRT-PCR
Entero/Ge/08) that detects all known EV genotypes was  per-
ormed as previously described [24,25]. As an internal control,
0 L of standardized Canine Distemper Virus was added to each
ample before extraction as previously described [26].l Virology 89 (2017) 22–29 23
3.3. EV typing
Extracted RNA from the CSF were reverse transcribed with ran-
dom hexamers (Roche, Indianapolis, IN, USA) using the reverse
transcriptase SuperScript II (Invitrogen, Carlsbad, CA, USA). The
VP1 (primers AN88 and AN89 [27]) and VP4/VP2 (primers F848
and adapted R1126 [28]) viral capsid regions were then ampliﬁed
by PCR and amplicons were puriﬁed with the MSB  Spin PCRa-
pace kit (Stratec, Birkenfeld, Germany) before sequencing on a
ABI Prism 3500XL DNA Sequencer (Applied Biosystems, Rotkreuz,
Switzerland). Sequences were analyzed with the Geneious Pro 6.1.8
analysis software (Biomatters Ltd, Auckland, New Zealand). EV typ-
ing analysis was  performed from blood or stool specimens when the
viral load in the CSF or CSF and blood were too low to obtain VP1
or VP4/VP2 amplicons.
3.4. Phylogenetic analysis
Sequence alignment was constructed using the MAFFT v7.017
multiple sequence alignment program [29]. Maximum-likelihood
trees for the VP1 and VP4/VP2 capsid regions were built using the
PhyML method [30] with one thousand bootstrap replicates.
3.5. Statistical analysis
Differences between groups were tested using the
Mann–Whitney U tests for continuous variables and the 2
test or Fisher’s exact test for categorical variables using GraphPad
Prism version 6.00 (GraphPad Software, La Jolla, CA, USA). A
two-sided p value of <0.05 was considered signiﬁcant.
4. Results
4.1. Demographic analysis
During the three-year study period, a total of 60 EV-associated
meningitis cases (37 pediatric and 23 adults) conﬁrmed by rRT-
PCR were detected at the University Hospitals of Geneva. Overall,
the age distribution ranged from 5 days to 40 years old (median
age, 4 months; Supplementary Fig. 1a) with a male-to-female ratio
of 1.1:1. When the pediatric and adult populations were analyzed
individually, the median age was  1 month and 29 years old, respec-
tively, with a male-to-female ratio of 1.6:1 and 0.6:1, respectively.
The monthly distribution showed that positive cases were more
prevalent during the warm season (April–September) (Supplemen-
tary Fig. 1b).
4.2. Viral shedding in pediatric versus adult subjects
Of a total of 42 pediatric patients (37 from Geneva; 5 from Lau-
sanne), stool, blood, upper respiratory and urine specimens were
obtained for 32, 37, 25 and 24 cases, respectively (Table 1). Among
the 23 adult patients (all from Geneva), stool, blood, upper respi-
ratory, and urine specimens were obtained for 12, 21, 15 and 12
cases, respectively (Table 1).
Urine and respiratory specimens showed a weak positive rate
that did not signiﬁcantly differ between the pediatric and adult
populations (Table 1). By contrast, the detection rate in stool and
blood specimens was signiﬁcantly different between the two popu-
lations. Positive rates in pediatric cases reached up to 91% and
68%, respectively, whereas they were only 25% and 29%, respec-
tively, in adults. CSF, blood, and stool specimens were obtained
for 32 pediatric cases and 12 adults. Out of 32 pediatric patients
(62.5%), 20 were positive in stool and blood in addition to the CSF
(Fig. 1), 9 were positive only in the CSF and stool samples, and
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Table 1
Comparison of EV detection rate in pediatric and adult subjects.
Stool Blood (plasma/serum) Respiratory (nasal swab/aspirate) Urine
Pediatric Adults Pediatric Adults Pediatric Adults Pediatric Adults
Total no. of specimens 32 12 37 21 25 15 24 12
No.  of positive specimens 29 3 25 6 10 2 5 2
(%)  (91) (25) (68) (29) (40) (13) (21) (17)
p  Value p < 0.0001 p = 0.0097 n.s n.s
n.s: not signiﬁcant.
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9ig. 1. Comparison of enterovirus detection rates in pediatric and adult subjects fo
:  EV-positive; −: EV-negative.
 cases were only positive in the CSF and blood. For the two lat-
er cases, stool could be collected only 4 and 6 days after lumbar
uncture. Only one case was positive in the CSF only (3.125%), thus
evealing that EV detection was positive in stool and/or blood in
ddition to the CSF specimen in 31 of 32 (96.9%) patients. Of note,
he VP1 and/or VP4/VP2 sequences were obtained for 18 of the 20
ediatric patients who were EV-positive in all three specimens. For
ach individual patient, the same EV genotype was  present in all
hree specimens and no intra-host variability was  observed (data
ot shown).
An analysis of viral shedding showed a completely different pat-
ern in adult subjects. No case was positive in all the three types of
pecimens and most adult subjects were only positive in the CSF
50%; Fig. 1).
Viral load measures were assessed for all EV-positive blood,
tool, respiratory and urine specimens, and all initial CSF spec-
mens (n = 59; 37/42 and 22/23 pediatric and adult subjects,
espectively) with a sufﬁcient leftover volume. The viral loads
n positive CSF, stool, urine and respiratory specimens were not
igniﬁcantly different between the pediatric and adult popu-
ations (Fig. 2a). By contrast, the results obtained with blood
pecimens showed that the viral load was signiﬁcantly higher in
ediatric cases (range, 1.81 × 102–5.05 × 107 copies/mL; median,
.89 × 105 copies/mL) compared to adults (range, 2.06 × 103 to
.8 × 104 copies/mL; median, 7.74 × 103 copies/mL) (Fig. 2a).m cerebrospinal ﬂuid, blood and stool samples were all collected. n: total number;
We  assessed whether a bias could be introduced due to time
intervals between the time of lumbar puncture and the collection
of other samples collected for the purpose of this study (i.e. stool,
respiratory and urine specimens; blood specimens were mostly col-
lected in parallel to CSF for clinical purposes). When the pediatric
and adult populations were analyzed separately, a comparative
analysis between EV-positive and -negative samples (e.g. pedi-
atric positive versus negative cases in blood) showed equivalent
intervals between positive and negative blood, stool and urine spec-
imens (Fig. 2b), irrespective of the population studied, except for
respiratory specimens (p = 0.0254) in the pediatric population (no
difference in adults). A further comparative analysis between the
two populations showed that the intervals did not differ between
both groups for the stool, urine and respiratory specimens (e.g. all
pediatric collected stool versus all adult collected stool), whereas
they were signiﬁcantly different (p = 0.0056) for blood specimens
(pediatric: median, 0 days; range, −1 to +4 days; adults: median, 0
days; range, 0 to +2 days) (data not shown).
Similarly to non-viremic and viremic adult patients (p = 0.1979),
the duration of symptoms before lumbar punctures was  not sig-
niﬁcantly different between non-viremic and viremic pediatric
subjects (p = 0.8654). Furthermore, the higher viral load observed
in pediatric cases compared to adult did not result from differ-
ent durations of symptoms before lumbar punctures between both
populations (p = 0.6736).
S. Cordey et al. / Journal of Clinical Virology 89 (2017) 22–29 25
Fig. 2. Analysis of enterovirus shedding. Pediatric subjects analyzed are from the University Hospitals of Geneva and the University Hospital Center in Lausanne; adults are
all  from the University Hospitals of Geneva. Viral loads (panel a) are given for cerebrospinal ﬂuid (CSF), blood, stool, urine and respiratory specimens. Pediatric and adult viral
loads  are represented by orange and grey plots, respectively. The CSF, blood and urine viral units are expressed in log10 genome copies/mL, whereas the stool and respiratory
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.3. Clinical characteristics
Clinical characteristics are presented in Table 2. Headache and
ever were the most frequent clinical manifestations reported in
hildren ≥3 years old (100%) and adults (100% and 78.3%, respec-
ively). Fever (100%), irritability (61.3%) and feeding difﬁculty
48.4%) were the most common clinical features documented in
nfants and neonates. A higher maximal body temperature was
bserved in pediatrics subjects compared to adults (Table 2). In
ontrast to infants and neonates, vomiting was frequently observed
n children ≥3 years old (50%) and adults (47.8%). Importantly, no
ifference in term of clinical severity was observed between the
ediatric and the adult populations.
While C-reactive protein (CRP) levels were not signiﬁcantly
ifferent between non-viremic and viremic adult patients (n = 15
nd 5, respectively), they were signiﬁcantly lower (p = 0.0203) in
on-viremic compared to viremic pediatric subjects (n = 9 and 21,
espectively; Fig. 3a). By contrast, a CSF cell count comparative
nalysis showed that whereas the number of leucocytes/mm3 was
ot signiﬁcantly different between non-viremic and viremic adult
atients (n = 15 and 6, respectively), it was signiﬁcantly higher
p = 0.0002) in non-viremic than in viremic pediatric subjects (n = 10
nd 24, respectively; Fig. 3b). Following the latter ﬁnding, EV viral
oads in CSF were compared between these two pediatric popula-
ions and were not statistically signiﬁcantly different (p = 0.4224;
edian for viremic and non-viremic pediatric subjects, 1.54 × 104
nd 7.85 × 103 EV copies/mL, respectively; data not shown).
.4. Distribution of EV genotypes
The EV genotype was determined for 62 of 65 cases. All but
ne genotype (EVA71; EV-A species) belonged to the EV-B species
Fig. 4a, Supplementary Figs. 2 and 3). Overall, the most frequent
enotype was  E30, representing up to 16.7% and 69.6% of pedi-
tric and adult cases, respectively (Fig. 4b). In 2013 and 2015, E30ar puncture and the collection of the different type of samples are represented by
displayed only when considered statistically signiﬁcant. (For interpretation of the
rticle.)
represented the most frequent genotype in the adult population (12
of 15 (80%) and 4 of 7 (57.1%) cases, respectively), and the most (2 of
5 cases, 40%) and second most (5 of 25 cases, 20%) frequent geno-
type in the pediatric population in Geneva, respectively. Of note,
E30 was not observed in 2014 in both populations. Furthermore,
the phylogenetic analyses showed the presence of two  temporal
E30 lineages in 2013 and 2015 (Supplementary Figs. 2 and 3).
The second most frequent genotype was  coxsackievirus (CV) B5
(19% and 13% of pediatric and adult cases, respectively). Although
there is no evidence for the presence of EV genotype restricted
to one population, the analysis showed a greater diversity of EV
genotypes detected in the pediatric populations (13 genotypes)
compared to those present in the adult populations (5 genotypes)
over the three-year study period. A predominance of E30 was
observed in children ≥3 years old and adults. Indeed, EV genotype
was obtained for 6 of 7 pediatric subjects ≥3 years old; ﬁve were
E30 positive. In contrast, E30 was  detected in only two  pediatrics
subjects <3 years old.
Although E30-associated viremia showed a weak positive rate
in the adult subjects (6 of 15 E30 cases), all EV-positive blood spec-
imens in this population were associated to this speciﬁc genotype.
This observation contrasted with the high positive rate in blood
samples that was not correlated to speciﬁc EV genotypes in the
pediatric population.
5. Discussion
In this prospective study, EV shedding was assessed for EV-
associated meningitis subjects and compared between pediatric
and adult populations over a three-year period. In parallel, a demo-
graphic and epidemiologic surveillance was  performed.In agreement with previous studies [3,5–7,22,31,32], we
showed that CNS-associated EV infection cases were more preva-
lent during the warm season (peaks in June or July). Positive
subjects were mostly neonates and infants under the age of three
26 S. Cordey et al. / Journal of Clinical Virology 89 (2017) 22–29
Table 2
Clinical characteristics of pediatric and adult subjects enrolled in Geneva with a diagnosis of EV meningitis.
Pediatric Adults
Age (median) 1 month 29 y.o
Sex  (male:female ratio) 1.6:1 0.6:1
C-reactive protein (mg/L) p = 0.0203 Non viremic (mean): 10 Non viremic (mean): 17.9 n.s
Viremic (mean): 16.3 Viremic (mean): 22.8
Cerebrospinal ﬂuid cell count
(leucocytes/L)
p = 0.0002 Non viremic (mean): 657.8 Non viremic (mean): 271.5 n.s
Viremic (mean): 150.6 Viremic (mean): 184.7
Duration of symptoms before lumbar
punctures (median, days)
Median: 0 p = 0.0015 Median: 1
Clinical presentation
Fever (%) 100 78.3
Fever  (median max temperature in ◦C) 38.9 p < 0.0001 38.1
Headache (%) ≥3 y.o: 100 100
Vomiting (%) 10.8 47.8
Neck  stiffness (%) ≥3 y.o: 16.7 30.4
Photophobia (%) ≥3 y.o: 83.3 43.5
Phonophobia (%) ≥3 y.o: 33.3 26.1
Nausea (%) ≥3 y.o: 16.7 17.4
Irritability (%) <1 y.o: 61.3
Feeding difﬁculty (%) <1 y.o: 48.4
n.s: not signiﬁcant; y.o: years old.
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tig. 3. Comparison of the blood C-reactive protein and the number of leucocytes/m
panel  a) and the number of leucocytes/mm3 in the cerebrospinal ﬂuid (panel b) be
 Values are displayed only when considered statistically signiﬁcant.
onths, as well as young adults (all ≤40 years old), thus sup-
orting that EV-associated meningitis is largely related to close
ontact with children in the latter population. Nevertheless, EV-
ssociated meningitis can be observed also in elderly patients
22,33]. Transplacental infections and transmissions at delivery
ere not investigated in this study as blood specimens from the
others were not collected.
The ability of many EV genotypes to infect the CNS has been
reviously described [2]. All belonged to the EV-B species, except
ne case that belonged to the EV-A species, thus conﬁrming the
redominance in Europe of EV-B species in EV-associated CNS
nfections [5,7,34,35]. Our data show that a large panel of EV geno-
ypes co-circulate and are responsible for CNS infection in neonates the cerebrospinal ﬂuid. Comparative analysis of the C-reactive protein (CRP) level
 viremic and non-viremic subjects enrolled at the University Hospitals of Geneva.
and infants compared to children ≥3 years old and adults where
EV genotypes appear to be more restricted, with a predominance
of E30 and CVB5. This suggests a different susceptibility between
these populations with regard to the diverse EV genotypes. E30 is
the most prevalent genotype detected in adults and children ≥ 3
years old with a lower representation in neonates and infants. This
is in agreement with recent ﬁndings [5]. CVB5, a genotype known to
cause EV meningitis outbreaks [36], represents the most frequent
genotype detected in our pediatric population. Importantly, we
did not observe any association between clinical signs/symptoms
and the presence of speciﬁc EV genotypes, nor between clinical
signs/symptoms and the presence/absence of viremia in the pedi-
atric and adult populations.
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dult  patients (panel b).
The comparative analysis of the EV detection rate in the different
utative sites of replication in pediatric and adult subjects revealed
he presence of two distinct viral shedding patterns. While low pos-
tive rates were observed for urine and respiratory samples in both
opulations, conﬁrming that these types of specimens represent
oor predictors in the case of suspicion of EV meningitis, stool and
lood showed a high positive rate for the pediatric population, but
emained low in adults. This observation was conﬁrmed when viral
hedding was compared in speciﬁc patients for whom CSF, blood
nd stool were obtained. Up to 62.5% of pediatric cases were pos-
tive in all three specimens (positivity rate reached 96.9% when
onsidering positivity in stool or blood, in addition to CSF; Fig. 1),
hus supporting the presence of disseminated EV infections, while
his was not the case for any adult in our study. This observation
eems not correlated to the uneven distribution of EV genotypes
etween the two populations, although this statement still needs
o be conﬁrmed by large comparative studies. Our results are in
greement with previous ﬁndings focusing either on pediatric EV-
ositive specimens [37] or both populations [38]. This suggests that
 systematic screening of EV in stool and blood samples by molec-
lar assays as the ﬁrst line of investigation may  either increase
he yield of detection of CNS-associated EV infection in pediatric
ubjects or may  be useful when lumbar puncture is contraindi-
ated or unavailable. Our analysis of the VP1 and VP4/VP2 regionsiversity Hospitals of Geneva and the University Hospital Center in Lausanne; adults
er a 3-year period (panel a). Distribution of enterovirus genotypes in pediatric and
conﬁrmed the presence of disseminated EV infection as the same
EV genotype was constantly present in all three specimens. This is a
relevant point as EV can replicate during several weeks in the gas-
trointestinal tract [39], meaning that the detection of EV in stool
may  not necessarily reﬂect the ongoing infection leading to CNS
infection.
The analysis of viral load in EV-positive pediatric and adult
CSF samples shows no signiﬁcant difference between both popu-
lations. This conﬁrms previous ﬁndings [35], with median values
similar to those obtained in our study (Fig. 2a). By contrast, the
viral load was signiﬁcantly higher for EV-positive blood specimens
in pediatric subjects. Although not signiﬁcantly different, a sim-
ilar trend was observed for positive stool specimens (p = 0.0593;
Fig. 2a). Interestingly, EV-positive blood specimens in adult subjects
were systematically associated with E30 genotype. The higher viral
load in the pediatric population was observed when all EV-positive
blood specimen were considered (uneven distribution of EV geno-
types between the pediatric and adult populations), while it was
not statistically signiﬁcantly different (p = 0.3939) when consider-
ing only E30-positive cases in both populations. This result supports
that the higher viral load observed in blood specimen in the pedi-
atric population reﬂects infections with different EV genotypes.
Our results strengthen the hypothesis of two  different pat-
terns of EV viral shedding in pediatric and adult subjects, with
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he presence of a high replication level in the gastrointestinal tract
ith sustained viremia observed in pediatric cases. The most likely
ypothesis for this observation is the presence of different immune
roﬁles between the pediatric and adult populations. In contrast
o children for whom the primary immune response seems to be
ostly engaged, disseminated infections are infrequent in adult
ubjects since the EV infections is likely partially controlled by some
egree of immune memory acquired from previous EV exposures.
hus, the CNS invasion may  directly result from a sustained viremia
ith a direct cross of viral particles through the blood–brain bar-
ier in pediatric subjects. Alternatively, viral CNS invasion might
ccur differently in adults, and could be achieved through the ret-
ograde transport pathway as proposed for other enteroviruses
40].
In conclusion, our study highlights the importance and the
eed for extensive investigation to assess the differences in
V viral shedding and genotype sensitivity between pediatric
nd adult subjects leading to CNS-associated EV infection. This
ould be valuable information for the clinician as it has the
otential to signiﬁcantly modify the current practices of patient
are.
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